Vasomotor rhinitis (mode)

RHINITIS_VASOMOTOR

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Check mode of ICD-10 codes: %J300 Registry filters: Hospital discharge: ICD-10 — J30.0 Cause of death: ICD-10 — J30.0 2 out of 7 registries used, show all original rules.	2860
4. Check minimum number of events None	2860
5. Include endpoints None	2860
6. Filter based on genotype QC (FinnGen only)	2860

Control definitions (FinnGen only)

Control exclude: ASTHMA_NOS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	RHINITIS_VASOMOTOR
CONTROL_EXCLUDE	ASTHMA_NOS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	%J300
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	%J300
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Vasomotor rhinitis (mode) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	18772	10965	7751
Only index persons	18144	10727	7417
Unadjusted period prevalence (%)
Whole population	0.27	0.31	0.22
Only index persons	0.35	0.39	0.28
Median age at first event (years)
Whole population	46.83	47.11	46.47
Only index persons	46.74	47.05	46.29

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2860	1834	1026
Unadjusted period prevalence (%)	0.56	0.63	0.45
Median age at first event (years)	50.99	48.66	55.17

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2560: Matched controls
25597

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R01AD09

ATC

mometasone; nasal

5.5

323.0

1868

8395

J30.0

ICD-10 Finland

Vasomotor rhinitis

4503599627370496.0

323.0

2558

R01AD08

ATC

fluticasone; nasal

4.7

272.8

1338

4878

J31.0

ICD-10 Finland

Chronic rhinitis

7.4

221.6

583

978

R01AD12

ATC

fluticasone furoate; nasal

3.4

167.7

1169

5104

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

3.6

160.3

915

3389

UDH02

NOMESCO Finland

Rhinopharyngoscopy

6.7

152.9

424

737

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

5.4

125.6

417

895

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

4.5

123.1

489

1270

J34.2

ICD-10 Finland

Deviated nasal septum

6.5

119.0

334

580

R01BA52

ATC

pseudoephedrine, combinations; oral

2.8

117.1

1095

5444

R03DC03

ATC

montelukast; oral

3.4

115.9

667

2381

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

6.5

111.7

313

540

R01AD01

ATC

beclometasone; nasal

3.4

111.1

644

2302

R01AX03

ATC

ipratropium bromide; nasal

11.5

108.9

211

199

DHB50

NOMESCO Finland

Turbinoplasty

9.2

105.8

231

272

XQ800

NOMESCO Finland

Prick test

4.5

98.4

385

969

R01AD05

ATC

budesonide; nasal

4.3

96.4

392

1023

R06AX27

ATC

desloratadine; oral

2.6

95.5

929

4584

R01AD11

ATC

triamcinolone; nasal

3.9

90.0

413

1200

J01.0

ICD-10 Finland

Acute maxillary sinusitis

2.7

89.3

772

3528

R03AC02

ATC

salbutamol; inhalant

2.3

86.2

1534

10125

H02AB06

ATC

prednisolone; systemic

2.2

80.3

1357

8620

J45.9

ICD-10 Finland

Asthma, unspecified

2.8

76.5

588

2468

J30.3

ICD-10 Finland

Other allergic rhinitis

6.5

76.5

209

344

J01AA02

ATC

doxycycline; systemic

2.5

75.8

2109

16681

J01FA10

ATC

azithromycin; systemic

2.1

70.4

1647

11755

DJD20

NOMESCO Finland

Plastic repair of septum of nose

5.6

66.4

206

397

R06AE07

ATC

cetirizine; oral

2.1

65.0

1278

8362

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

8.3

64.9

149

189

A02BC05

ATC

esomeprazole; systemic

2.0

62.3

1158

7364

J45.1

ICD-10 Finland

Nonallergic asthma

3.8

61.1

285

825

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.0

61.0

1415

9788

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

6.6

56.7

151

239

TDM10

NOMESCO Finland

Puncture of maxillary antrum

4.9

54.3

186

400

ZXC60

NOMESCO Finland

Application of heat

8.6

53.3

119

144

UDQ12

NOMESCO Finland

Flexible laryngoscopy

4.0

52.5

224

598

UDM02

NOMESCO Finland

Sinoscopy

7.4

52.0

128

181

J01CA04

ATC

amoxicillin; systemic

2.1

51.2

2114

17617

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

2.3

50.9

560

2779

R06AE09

ATC

levocetirizine; oral

2.4

50.1

485

2256

DNB20

NOMESCO Finland

Endoscopic ethmoidectomy

6.5

50.1

135

217

R06.0

ICD-10 Finland

Dyspnoea

2.1

49.0

691

3829

R03BA02

ATC

budesonide; inhalant

2.3

48.1

528

2609

Z01.8

ICD-10 Finland

Other specified special examinations

2.1

47.0

618

3312

R05

ICD-10 Finland

Cough

2.2

46.4

575

3000

R06AX22

ATC

ebastine; oral

2.2

45.9

538

2736

R03BA05

ATC

fluticasone; inhalant

2.2

45.2

533

2714

A02BC03

ATC

lansoprazole; oral

1.9

44.0

809

4934

J01FA09

ATC

clarithromycin; systemic

1.9

43.7

891

5642

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.9

42.7

290

1095

H02AB04

ATC

methylprednisolone; systemic

2.3

41.9

437

2092

M03BX02

ATC

tizanidine; oral

1.8

40.4

1614

12592

R03AC03

ATC

terbutaline; inhalant

2.3

39.3

420

2027

R09

ICPC

Sinus symptom/complaint

2.8

39.1

266

1003

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

4.4

39.1

148

352

R06AX13

ATC

loratadine; oral

2.2

38.9

473

2424

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.8

38.9

1132

7974

J33.8

ICD-10 Finland

Other polyp of sinus

7.5

38.2

126

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.9

37.0

719

4420

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

4.1

36.9

151

387

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

4.3

36.8

144

354

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.8

35.2

746

4708

J01FA06

ATC

roxithromycin; oral

1.7

34.4

1042

7336

J33.0

ICD-10 Finland

Polyp of nasal cavity

5.2

33.3

106

210

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

33.1

1031

7295

N02BE01

ATC

paracetamol; systemic, rectal

1.9

33.0

2164

18982

J01DB01

ATC

cefalexin; oral

1.8

32.8

2062

17800

A02BC02

ATC

pantoprazole; systemic

1.7

32.4

1612

12955

R03BA01

ATC

beclometasone; inhalant

2.1

32.3

405

2090

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

32.0

637

3914

R06.5

ICD-10 Finland

Mouth breathing

2.5

31.2

267

1146

G47.3

ICD-10 Finland

Sleep apnoea

1.9

31.0

550

3243

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

30.7

895

6176

XG474

NOMESCO Finland

Exhalation nntrogen oxide

4.6

30.7

110

248

A02BA02

ATC

ranitidine; systemic

1.9

30.6

507

2914

J02AC01

ATC

fluconazole; systemic

1.6

30.2

1064

7731

R03AK07

ATC

formoterol and budesonide; inhalant

1.9

29.6

507

2944

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

29.3

353

1785

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

6.4

29.2

125

UJF32

NOMESCO Finland

Coloscopy

1.8

28.9

643

4075

A02BC01

ATC

omeprazole; systemic

1.7

28.6

706

4617

R51.80

ICD-10 Finland

Headache

2.0

27.3

399

2176

N03AX12

ATC

gabapentin; oral

2.0

26.9

411

2282

J45

ICD-10 Finland

Asthma

2.3

26.0

270

1271

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.8

26.0

174

647

N03AX16

ATC

pregabalin; oral

1.7

25.6

590

3756

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.2

25.5

274

1310

M79.6

ICD-10 Finland

Pain in limb

1.6

25.5

875

6231

R03BA08

ATC

ciclesonide; inhalant

2.4

25.4

239

1074

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.2

25.2

274

1316

J01DA01

ATC

[U] cefalexin; systemic

1.6

25.0

1547

12697

R96

ICPC

Asthma

2.3

24.7

245

1129

M25.5

ICD-10 Finland

Pain in joint

1.7

24.6

718

4888

J32.2

ICD-10 Finland

Chronic ethmoidal sinusitis

8.3

24.4

J32.4

ICD-10 Finland

Chronic pansinusitis

7.0

24.2

J34.1

ICD-10 Finland

Cyst and mucocele of nose and nasal sinus

5.6

24.0

130

M54.5

ICD-10 Finland

Low back pain

1.6

23.9

808

5711

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.9

23.7

375

2099

M01AH05

ATC

etoricoxib; oral

1.5

23.6

1451

11809

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

3.0

23.4

141

490

H04.10

ICD-10 Finland

Dry eye syndrome

2.1

23.4

281

1411

XG410

NOMESCO Finland

Flow-volume spirometry

3.2

23.2

128

419

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

23.1

347

1904

A02BC04

ATC

rabeprazole; oral

2.2

22.9

238

1120

Z00.0

ICD-10 Finland

General medical examination

1.8

22.6

459

2796

R03BC03

ATC

nedocromil; inhalant

2.4

22.4

204

901

R53

ICD-10 Finland

Malaise and fatigue

1.7

21.8

474

2949

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.2

21.1

225

1068

R06.2

ICD-10 Finland

Wheezing

2.9

21.1

129

454

S01GX01

ATC

cromoglicic acid; ophthalmic

1.7

21.0

515

3314

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

21.0

260

1321

J32.9

ICD-10 Finland

Chronic sinusitis, unspecified

6.4

21.0

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

2.0

20.8

289

1536

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

20.4

1107

8649

R05FA02

ATC

opium derivatives and expectorants; systemic

1.5

19.9

978

7468

M01AE02

ATC

naproxen; oral, rectal

1.5

19.9

1386

11391

SPAT1263

SPAT

Sampling

1.5

19.8

1014

7807

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.5

19.8

982

7511

R03AK08

ATC

formoterol and beclometasone; inhalant

3.1

19.8

113

379

UDC00

NOMESCO Finland

Ear microscopy

2.3

19.7

197

910

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

2.6

19.6

144

567

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.3

19.6

190

864

ZXA10

NOMESCO Finland

Bilateral

1.7

19.4

434

2713

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

19.1

686

4864

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

18.8

609

4208

L03

ICPC

Low back symptom/complaint

1.6

18.6

565

3840

R75

ICPC

Sinusitis acute/chronic

2.6

18.6

135

528

SPAT1310

SPAT

Counselling related to known health issue

1.5

18.5

760

5552

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.5

18.4

679

4841

J01FA15

ATC

telithromycin; oral

1.9

18.2

267

1448

J35.0

ICD-10 Finland

Chronic tonsillitis

2.5

18.2

145

597

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

3.1

18.2

103

342

N06AX21

ATC

duloxetine; oral

1.9

18.2

276

1516

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.6

18.1

530

3566

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

18.0

410

2569

J45.8

ICD-10 Finland

Mixed asthma

3.4

18.0

259

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

17.9

546

3709

SPAT1301

SPAT

No procedures

1.5

17.8

729

5316

R01AC02

ATC

levocabastine; nasal

3.2

17.7

301

K07.60

ICD-10 Finland

Snapping jaw

2.5

17.6

139

570

E0000UV

ATC

1.5

17.6

935

7202

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

17.5

348

2095

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.6

17.5

552

3781

SPAT1153

SPAT

Removal of sutures

1.5

17.5

743

5454

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.8

17.4

323

1901

R07

ICPC

Sneezing/nasal congestion

2.3

17.4

166

752

G44.2

ICD-10 Finland

Tension-type headache

1.8

17.3

341

2043

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

17.3

1696

14715

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.8

17.1

293

1682

SPAT1312

SPAT

General health counselling

1.5

16.9

750

5553

M54.2

ICD-10 Finland

Cervicalgia

2.2

16.8

181

865

N02AX02

ATC

tramadol; systemic, rectal

1.4

16.7

965

7538

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

2.3

16.7

161

730

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

16.7

150

659

R06AX26

ATC

fexofenadine; oral

2.2

16.6

178

850

J30

ICD-10 Finland

Vasomotor and allergic rhinitis

4.7

16.6

121

R08

ICPC

Nose symptom/complaint other

3.1

16.6

299

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

16.5

388

2453

L17

ICPC

Foot/toe symptom/complaint

1.5

16.3

570

3994

S18

ICPC

Laceration/cut

1.4

16.2

946

7399

M01AB05

ATC

diclofenac; systemic, rectal

1.4

15.9

1610

13923

K30

ICD-10 Finland

Functional dyspepsia

1.9

15.9

256

1436

XQ802

NOMESCO Finland

Epicutan test

2.6

15.7

117

465

R07.0

ICD-10 Finland

Pain in throat

2.2

15.6

161

756

J46

ICD-10 Finland

Status asthmaticus

3.4

15.4

231

M01AC06

ATC

meloxicam; systemic, rectal

1.4

15.3

863

6681

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

15.3

1251

10376

C05AA08

ATC

fluocortolone; rectal, topical

1.7

15.1

337

2093

R05

ICPC

Cough

1.5

15.0

517

3601

M48.0

ICD-10 Finland

Spinal stenosis

1.8

15.0

268

1555

A07AA02

ATC

nystatin; oral

2.2

14.8

151

704

J31

ICD-10 Finland

Chronic rhinitis, nasopharyngitis and pharyngitis

5.5

14.8

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

14.7

850

6600

M54.4

ICD-10 Finland

Lumbago with sciatica

1.6

14.6

390

2548

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.4

14.6

1141

9358

R21

ICPC

Throat symptom/complaint

1.6

14.5

451

3062

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

14.4

369

2383

R05FB02

ATC

cough suppressants and expectorants

1.4

14.4

859

6704

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

2.7

14.4

101

389

J01MA02

ATC

ciprofloxacin; systemic

1.4

14.3

853

6657

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.5

14.2

108

435

J01DC02

ATC

cefuroxime; systemic

2.2

14.1

148

699

R01BA01

ATC

phenylpropanolamine; oral

2.2

14.1

141

654

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.8

14.1

246

1417

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

14.0

860

6736

R03AC13

ATC

formoterol; inhalant

2.3

14.0

127

561

A01AB09

ATC

miconazole; local oral

1.9

14.0

214

1177

N05CF01

ATC

zopiclone; oral

1.4

13.8

707

5345

R74

ICPC

Upper respiratory infection acute

1.5

13.8

646

4799

DPA25

NOMESCO Finland

Trephine of frontal sinus through nose

9.1

13.7

P01AB01

ATC

metronidazole; oral, rectal

1.4

13.7

923

7349

SPAT1058

SPAT

PEF monitoring instruction

1.9

13.6

200

1084

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

13.6

1515

13131

M79.1

ICD-10 Finland

Myalgia

1.7

13.3

300

1869

R03BB04

ATC

tiotropium bromide; inhalant

1.9

13.1

206

1144

A01AB04

ATC

amphotericin B; local oral

2.3

13.1

118

520

G04CA02

ATC

tamsulosin; oral

1.6

12.9

396

2672

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

12.9

600

4446

M01AH02

ATC

rofecoxib; oral

1.7

12.5

290

1818

C07AB07

ATC

bisoprolol; oral

1.4

12.4

981

7986

N05BA04

ATC

oxazepam; oral

1.5

12.4

546

3995

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

12.4

721

5563

J01DA06

ATC

[U] cefuroxime; systemic

1.6

12.3

339

2226

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

12.1

895

7199

N06AX11

ATC

mirtazapine; oral

1.4

12.1

703

5422

DHB20

NOMESCO Finland

Polypectomy of internal nose

4.6

12.0

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

12.0

258

1585

J01FF01

ATC

clindamycin; systemic

1.4

11.9

609

4584

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

11.9

630

4773

J01

ICD-10 Finland

Acute sinusitis

2.2

11.9

116

533

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.7

11.8

245

1487

R49.01

ICD-10 Finland

Functional dysphonia

2.7

11.8

315

L08

ICPC

Shoulder symptom/complaint

1.5

11.7

414

2884

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

11.7

514

3751

D07AC01

ATC

betamethasone; topical

1.4

11.7

739

5777

M02AA07

ATC

piroxicam; topical

1.4

11.6

817

6504

N06AA09

ATC

amitriptyline; systemic

1.7

11.6

230

1380

SPAT1059

SPAT

Spirometry at the office

2.1

11.6

124

594

KMAK

NOMESCO Finland

1.3

11.6

1208

10244

J05AB01

ATC

aciclovir; systemic

1.5

11.6

478

3448

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

11.5

920

7479

J01MA14

ATC

moxifloxacin; systemic

1.8

11.5

197

1127

N06AB04

ATC

citalopram; systemic

1.5

11.5

482

3489

R03AC12

ATC

salmeterol; inhalant

2.3

11.5

102

448

DMB00

NOMESCO Finland

Endonasal trephine of maxillary antrum

4.9

11.4

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.5

11.4

433

3065

M54

ICD-10 Finland

Dorsalgia

1.7

11.4

249

1537

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.5

11.4

373

M70.6

ICD-10 Finland

Trochanteric bursitis

1.7

11.3

269

1697

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

11.2

379

2611

DPA30

NOMESCO Finland

Sphenotomy

7.3

11.2

G50.1

ICD-10 Finland

Atypical facial pain

3.4

11.2

153

DCA10

NOMESCO Finland

Paracentesis of tympanic membrane

3.9

11.1

118

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

11.1

382

2643

-1

NOMESCO Finland

1.4

11.0

748

5906

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.6

11.0

274

1754

G04CB02

ATC

dutasteride; oral

2.2

10.9

116

552

R52.9

ICD-10 Finland

Pain, unspecified

1.8

10.9

187

1072

R49.08

ICD-10 Finland

Other specified dysphonia

3.0

10.9

201

UKC02

NOMESCO Finland

Cystoscopy

1.6

10.8

316

2104

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

10.8

918

7509

J47

ICD-10 Finland

Bronchiectasis

3.6

10.8

137

M01AX17

ATC

nimesulide; oral

1.4

10.7

551

4137

N41.1

ICD-10 Finland

Chronic prostatitis

3.3

10.7

164

SHA03

NOMESCO Finland

Correction of physiology of bite - demanding therapy visit

2.5

10.7

332

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.1

10.7

115

551

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

10.7

609

4659

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.3

10.7

1109

9357

EMB10

NOMESCO Finland

Tonsillectomy

2.0

10.6

130

657

J01MA12

ATC

levofloxacin; systemic

1.5

10.6

379

2642

DHW99

NOMESCO Finland

Other operation on nose

60.2

10.6

J01AA04

ATC

lymecycline; systemic

1.6

10.6

288

1886

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

10.5

307

2044

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

10.5

692

5431

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

10.5

662

5155

G04CA01

ATC

alfuzosin; oral

1.7

10.4

205

1224

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.9

10.4

153

834

A06AC51

ATC

ispaghula, combinations; systemic

2.0

10.3

122

611

J34.8

ICD-10 Finland

Other specified disorders of nose and nasal sinuses

4.3

10.3

R13

ICD-10 Finland

Dysphagia

1.9

10.2

143

763

A03FA02

ATC

cisapride; oral, rectal

1.8

10.1

171

976

XF402

NOMESCO Finland

ECG with work load test

1.7

10.1

233

1458

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.7

10.1

202

1215

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

10.0

351

2435

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.8

10.0

161

901

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

10.0

234

1472

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

10.0

245

1561

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

10.0

186

1097

H13

ICPC

Plugged feeling ear

1.5

9.8

360

2523

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.0

9.8

130

680

H02AB07

ATC

prednisone; oral

1.5

9.8

307

2081

R03DC01

ATC

zafirlukast; oral

3.4

9.8

133

WZA90

NOMESCO Finland

Other doctors statement

1.4

9.7

501

3760

A03CA02

ATC

clidinium and psycholeptics; oral

2.0

9.7

129

675

XQ809

NOMESCO Finland

55.2

9.6

R5140

NOMESCO Finland

Monitoring the use of the aid

1.7

9.6

212

1312

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.3

9.5

400

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

9.4

1596

14320

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

9.4

220

1384

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.8

9.4

161

924

4730A

ICD-9 Finland

Chronic sinusitis, Maxillary

3.5

9.3

122

R03AK11

ATC

formoterol and fluticasone; inhalant

2.7

9.3

223

N05CF02

ATC

zolpidem; oral

1.5

9.3

390

2811

XF404

NOMESCO Finland

Ambulatory ECG

1.7

9.3

190

1151

K02.1

ICD-10 Finland

Caries of dentine

1.3

9.2

1289

11248

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.1

9.2

464

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

9.2

349

2465

L50.3

ICD-10 Finland

Dermatographic urticaria

3.2

9.0

147

SAA03

NOMESCO Finland

Extended examination of mouth

1.3

9.0

853

7044

G43.9

ICD-10 Finland

Migraine, unspecified

1.9

9.0

130

703

DCA20

NOMESCO Finland

Insertion of ventilating tube through tympanic membrane

3.1

9.0

153

L01

ICPC

Neck symptom/complaint

1.5

9.0

292

1994

R03DA04

ATC

theophylline; systemic, rectal

2.1

8.9

477

L15

ICPC

Knee symptom/complaint

1.4

8.9

440

3269

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

8.9

2190

20669

N40

ICD-10 Finland

Hyperplasia of prostate

1.5

8.9

335

2362

H92.0

ICD-10 Finland

Otalgia

2.0

8.9

115

598

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

2.5

8.8

274

M01AX01

ATC

nabumetone; oral

2.0

8.8

103

514

M02AA10

ATC

ketoprofen; topical

1.5

8.8

329

2317

E000001

ATC

1.4

8.7

440

3281

R02

ICPC

Shortness of breath/dyspnoea

1.6

8.7

241

1584

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

8.7

164

969

M03BC01

ATC

orphenadrine (citrate); systemic

1.4

8.7

537

4150

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.9

8.7

129

705

SPAT1260

SPAT

Consultation of another employee

1.4

8.7

379

2750

D07CC01

ATC

betamethasone and antibiotics; topical

1.5

8.6

274

1858

M75

ICD-10 Finland

Shoulder lesions

2.1

8.6

462

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

2.4

8.6

309

XKC03

NOMESCO Finland

Water cystometry

2.3

8.6

337

XCC00

NOMESCO Finland

Investigative irrigation of lacrimal passages

3.6

8.5

100

H01

ICPC

Ear pain/earache

1.6

8.4

224

1456

SPAT1081

SPAT

Cardiorespiratory global assessment

1.9

8.4

115

610

A02BA04

ATC

nizatidine; systemic

1.7

8.4

161

956

ENC30

NOMESCO Finland

Plastic operation of pharynx

3.5

8.4

107

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

8.3

401

2963

F45.8

ICD-10 Finland

Other somatoform disorders

1.8

8.3

150

873

C09CA06

ATC

candesartan; oral

1.4

8.3

447

3369

H29

ICPC

Ear symptom/complaint other

1.6

8.3

203

1292

K59.09

ICD-10 Finland

Constipation, unspecified

1.9

8.3

116

620

H02

ICPC

Hearing complaint

1.6

8.3

229

1506

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

8.2

146

849

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

8.2

135

766

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.6

8.2

228

1502

R01AC01

ATC

cromoglicic acid; nasal

2.1

8.2

440

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.5

8.1

264

1802

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

8.1

946

8018

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

8.1

1239

10867

SBB10

NOMESCO Finland

Teeth copy

1.8

8.1

132

748

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.3

8.1

620

4951

XG404

NOMESCO Finland

Peak expiratory flow (PEF) measurement

4.8

8.1

J32.1

ICD-10 Finland

Chronic frontal sinusitis

6.3

8.0

F51.0

ICD-10 Finland

Nonorganic insomnia

1.5

8.0

271

1868

R51.81

ICD-10 Finland

Facial pain NOS

2.6

8.0

203

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.6

7.9

219

1436

M01AX05

ATC

glucosamine; oral

1.4

7.9

393

2917

UJH02

NOMESCO Finland

Anoscopy

2.1

7.9

444

XKD00

NOMESCO Finland

Uroflowmetry

1.5

7.9

278

1928

S01GX02

ATC

levocabastine; ophthalmic

1.8

7.9

139

808

H03AA01

ATC

levothyroxine sodium; systemic

1.4

7.9

500

3878

M02AA15

ATC

diclofenac; topical (antiinflammatory prep., non-steroids for topical use)

1.7

7.8

159

963

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

7.8

144

849

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.5

7.8

284

1988

R01AD

ATC

Corticosteroids

3.4

7.8

103

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.6

7.8

185

1170

R05DA01

ATC

ethylmorphine; oral

1.7

7.8

169

1045

C07AA05

ATC

propranolol; systemic

1.4

7.8

416

3133

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.6

7.7

198

1279

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.4

7.6

412

3105

L82

ICD-10 Finland

Seborrhoeic keratosis

1.4

7.6

316

2271

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.9

7.6

109

593

SPAT1325

SPAT

Vaccination

1.3

7.6

710

5831

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.3

7.5

1295

11479

AN1

Coronary angiography

1.6

7.5

207

1361

Z01.2

ICD-10 Finland

Dental examination

1.3

7.5

899

7623

H66.9

ICD-10 Finland

Otitis media, unspecified

1.8

7.5

114

632

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

7.5

322

2329

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.3

7.4

963

8241

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

2.0

7.4

492

Z00.8

ICD-10 Finland

Other general examinations

1.7

7.4

147

884

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.6

7.4

189

1218

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.3

7.4

269

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.6

7.4

207

1364

J37.0

ICD-10 Finland

Chronic laryngitis

2.1

7.4

369

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.6

7.3

191

1235

H25.8

ICD-10 Finland

Other senile cataract

1.6

7.3

174

1102

G04CB01

ATC

finasteride; oral (testosterone-5-alpha reductase inhibitors)

1.6

7.3

164

1021

J31.1

ICD-10 Finland

Chronic nasopharyngitis

4.2

7.3

K60.1

ICD-10 Finland

Chronic anal fissure

2.5

7.3

227

A03

ICPC

Fever

1.4

7.3

314

2273

J20

ICD-10 Finland

Acute bronchitis

1.6

7.2

198

1299

C10AA03

ATC

pravastatin; oral

1.7

7.2

135

797

R01AC03

ATC

azelastine; nasal

5.8

7.2

N02CC04

ATC

rizatriptan; oral

1.7

7.2

129

754

L16

ICPC

Ankle symptom/complaint

1.6

7.1

201

1327

SAA04

NOMESCO Finland

Special inverstigation of mouth

1.8

7.1

120

689

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

1.9

7.1

518

R15

ICD-10 Finland

Faecal incontinence

2.4

7.1

254

M77.1

ICD-10 Finland

Lateral epicondylitis

1.7

7.0

150

919

D01

ICPC

Abdominal pain/cramps general

1.5

7.0

218

1472

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

7.0

135

805

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

2.1

7.0

364

C10AA07

ATC

rosuvastatin; oral

1.3

7.0

471

3676

R50.9

ICD-10 Finland

Fever, unspecified

1.5

7.0

270

1908

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

7.0

367

2751

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

7.0

542

4324

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.8

7.0

124

721

R00.2

ICD-10 Finland

Palpitations

1.7

7.0

141

852

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.5

6.9

240

1663

J01DC04

ATC

cefaclor; oral

3.0

6.9

125

R29

ICPC

Respiratory symptom/complaint other

1.7

6.9

127

750

DHB40

NOMESCO Finland

Conchotomy

13.8

6.9

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.7

6.9

140

848

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.6

6.9

180

1166

D06BX01

ATC

metronidazole; topical

1.5

6.9

219

1490

L02

ICPC

Back symptom/complaint

1.6

6.9

180

1168

N81.6

ICD-10 Finland

Rectocele

1.7

6.9

137

829

AA1AD

NOMESCO Finland

CT of head and brain

1.3

6.8

455

3547

4226

FHL

Posterior radical surgery and possible etmoidectomy

4.8

6.8

J32

ICD-10 Finland

Chronic sinusitis

4.8

6.8

L57.0

ICD-10 Finland

Actinic keratosis

1.6

6.8

172

1105

D07AC13

ATC

mometasone; topical

1.3

6.8

598

4856

R35

ICD-10 Finland

Polyuria

1.8

6.8

119

691

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.5

6.8

269

1916

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

6.8

190

1253

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

6.7

327

2416

Z46.1

ICD-10 Finland

Fitting and adjustment of hearing aid

1.8

6.7

115

663

R07.3

ICD-10 Finland

Other chest pain

1.6

6.7

183

1198

SPAT1097

SPAT

Recording of ECG

1.4

6.7

292

2114

H25.0

ICD-10 Finland

Senile incipient cataract

1.8

6.7

111

634

SPAT1202

SPAT

Intra-articular injection

2.1

6.7

349

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.9

6.7

523

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.6

6.7

150

935

207

Kela drug reimbursment

Chronic arrhythmias

1.5

6.7

248

1739

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

6.6

242

1694

S83.2

ICD-10 Finland

Tear of meniscus, current

1.7

6.6

141

865

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

2.0

6.6

407

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.4

6.5

316

2339

J01DA08

ATC

[U] cefaclor; oral

1.5

6.5

233

1627

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

3.6

6.5

SPAT1193

SPAT

Pap smear

1.5

6.5

197

1328

R42

ICD-10 Finland

Dizziness and giddiness

1.3

6.5

433

3379

H69.0

ICD-10 Finland

Patulous Eustachian tube

5.3

6.5

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.3

6.5

540

4353

R03AK03

ATC

[D] fenoterol & other drugs for obstructive airway dis; inhalant

1.8

6.4

535

L86

ICPC

Back syndrome with radiating pain

1.7

6.4

114

666

N04BC05

ATC

pramipexole; oral

1.6

6.4

144

898

WX110

NOMESCO Finland

Local anesthesy

1.2

6.4

1569

14358

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.4

6.4

344

2592

R03BB01

ATC

ipratropium bromide; inhalant

2.0

6.4

358

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.9

6.3

467

C08DA01

ATC

verapamil; systemic

1.9

6.3

424

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.7

6.3

123

736

K59.0

ICD-10 Finland

Constipation

1.8

6.3

107

616

R60.0

ICD-10 Finland

Localized oedema

1.5

6.3

203

1384

CJB10

NOMESCO Finland

Laser discission of secondary cataract

1.7

6.3

131

803

DM1ZD

NOMESCO Finland

+∞

6.3

H26.4

ICD-10 Finland

After-cataract

1.6

6.2

150

952

M13.9

ICD-10 Finland

Arthritis, unspecified

1.6

6.2

139

867

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.3

6.2

571

4657

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.9

6.2

493

T78.4

ICD-10 Finland

Allergy, unspecified

1.8

6.2

527

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

6.2

519

4181

G04BD12

ATC

mirabegron; oral

1.5

6.2

192

1298

SDA02

NOMESCO Finland

Parodonthologic therapy

1.3

6.2

678

5657

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.6

6.2

159

H04.5

ICD-10 Finland

Stenosis and insufficiency of lacrimal passages

2.4

6.1

203

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

6.1

160

1036

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.5

6.1

233

1647

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

6.1

521

4206

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.6

6.1

155

999

C05AA01

ATC

hydrocortisone; rectal, topical

1.8

6.1

102

586

K59.1

ICD-10 Finland

Functional diarrhoea

1.8

6.1

538

D80.3

ICD-10 Finland

Selective deficiency of immunoglobulin G [IgG] subclasses

12.5

6.1

J01FA01

ATC

erythromycin; systemic

1.4

6.1

294

2171

K03.00

ICD-10 Finland

Approximal wear

1.8

6.1

556

M54.6

ICD-10 Finland

Pain in thoracic spine

1.6

6.1

136

851

XJH00

NOMESCO Finland

Transanal ultrasonography

1.7

6.1

112

660

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.5

6.0

219

1533

M75.8

ICD-10 Finland

Other shoulder lesions

2.0

6.0

368

R30.1

ICD-10 Finland

Vesical tenesmus

2.7

6.0

147

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3013707) Erythrocyte sedimentation rate by Westergren method

2176

17742

1.95

49.11

5.0

4.0

mm/h

10.9

11.9

3.08

2026

16471

(3005322) IgE [Units/volume] in Serum or Plasma

338

1492

2.44

45.90

1.5

1.2

u/ml

208.0

200.7

0.03

315

1377

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

2215

18784

1.79

36.32

4.7

4.1

pmol/l

14.9

14.7

2.81

2030

17221

(3013115) Eosinophils [#/volume] in Blood

1587

12369

1.64

35.37

6.0

e9/l

0.2

4.36

1440

10878

(4010399)

332

1629

2.17

34.74

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1185

8637

1.64

34.26

3.8

3.5

ng/l

81.6

105.7

0.13

761

5682

(3037467) Urinalysis macro (dipstick) panel - Urine

1963

16370

1.63

31.24

4.8

4.2

—

(3006315) Basophils [#/volume] in Blood

1519

11947

1.58

30.72

5.9

5.8

e9/l

0.0

0.75

1364

10330

(3001604) Monocytes [#/volume] in Blood

1511

11903

1.57

30.09

5.9

5.8

e9/l

0.6

0.99

1357

10289

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2632

23986

2.22

29.90

15.5

13.6

mg/l

19.5

22.9

6.54

2126

18908

(3019198) Lymphocytes [#/volume] in Blood

1543

12255

1.56

29.32

5.9

5.8

e9/l

2.0

1.9

0.31

1406

10825

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2477

22182

1.87

28.32

5.7

4.8

mu/l

1.8

2.1

1.75

2307

20440

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

1009

7364

1.57

27.30

2.6

2.5

u/l

55.6

56.5

0.33

928

6796

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

630

4120

1.68

26.60

1.3

u/ml

10.7

11.5

0.10

243

1629

(3019150) Specific gravity of Urine by Refractometry

742

5096

1.62

25.68

4.4

4.0

kg/l

1.0

0.06

119

727

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2119

18379

1.59

25.05

7.5

u/l

74.3

77.5

4.06

1998

17326

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

770

5386

1.59

24.49

1.3

u/ml

2.2

1.6

0.34

230

1447

(3031040) Bacteria [#/volume] in Urine by Automated count

1846

15611

1.51

23.71

5.0

4.4

e6/l

1063.9

1936.9

0.48

216

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

636

4288

1.62

23.44

1.3

iu/ml

32.3

33.8

0.08

186

1350

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1162

8995

1.49

22.77

4.2

3.7

—

(40761511) CBC panel - Blood by Automated count

2685

25034

2.19

22.70

15.8

12.8

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1257

9958

1.47

21.53

2.5

2.2

nmol/l

78.8

77.3

1.04

1142

9002

(3029937) Albumin [Presence] in Urine by Test strip

855

6288

1.51

21.11

4.7

4.0

estimate

0.0

0.06

250

2128

(3019069) Monocytes/100 leukocytes in Blood

1384

11217

1.45

20.78

6.5

6.3

8.4

8.5

0.63

1292

10515

(3007164) IgA [Mass/volume] in Serum or Plasma

671

4719

1.55

20.24

1.5

1.4

g/l

2.2

2.4

2.48

422

2919

(3006504) Eosinophils/100 leukocytes in Blood

1374

11155

1.45

20.24

6.1

6.0

3.1

2.8

4.08

1283

10399

(3009261) Glucose [Presence] in Urine by Test strip

1443

11827

1.44

20.17

4.1

3.6

estimate

0.0

0.28

251

2127

(3021601) Nitrite [Presence] in Urine by Test strip

1430

11702

1.44

20.15

5.1

4.8

estimate

0.0

0.50

253

2195

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1308

10530

1.45

20.12

3.2

2.8

ug/l

98.5

117.0

4.57

1212

9774

(3018010) Neutrophils/100 leukocytes in Blood

1394

11371

1.44

19.88

6.0

5.8

55.9

57.0

2.78

1293

10652

(3002030) Lymphocytes/100 leukocytes in Blood

1411

11540

1.44

19.81

6.2

6.0

29.3

28.3

3.00

1310

10770

(3037522) Nuclear Ab [Titer] in Serum

506

3352

1.62

19.66

1.4

1.3

titre

497.1

563.0

0.34

103

711

(3013650) Neutrophils [#/volume] in Blood by Automated count

1648

13885

1.44

19.58

8.0

9.1

e9/l

3.9

4.0

1.02

1482

12132

(3022096) Basophils/100 leukocytes in Blood

1333

10830

1.43

19.18

6.2

6.0

0.7

0.47

1241

10116

(3035350) Ketones [Presence] in Urine by Test strip

1416

11661

1.42

18.73

4.0

3.6

estimate

0.0

0.50

238

2144

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

4.82

18.47

1.1

u/ml

8.7

11.6

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1407

11597

1.42

18.38

6.6

6.7

mmol/l

1.2

0.64

1181

9811

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

165

3.63

18.23

1.3

1.2

u/ml

0.1

0.2

1.65

(42870588) Differential panel, method unspecified - Blood

1028

8030

1.44

18.01

5.9

—

(3019550) Sodium [Moles/volume] in Serum or Plasma

2621

24545

1.81

17.17

17.0

15.4

mmol/l

139.7

0.55

2567

23951

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2509

23230

1.65

16.99

5.1

4.4

mmol/l

5.8

5.9

2.21

2317

21294

(3023103) Potassium [Moles/volume] in Serum or Plasma

2625

24618

1.81

16.77

17.0

15.6

mmol/l

4.0

0.84

2566

23985

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

911

7058

1.43

16.31

2.2

2.1

u/l

163.2

216.8

1.49

841

6639

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1467

12342

1.39

16.14

5.1

6.2

umol/l

10.9

11.1

0.33

1372

11704

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

822

6261

1.44

16.12

3.0

ng/l

1372.2

1228.5

0.21

677

5339

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

431

2878

1.59

15.95

6.7

6.8

—

(40760892) CBC W Ordered Manual Differential panel - Blood

720

5362

1.46

15.88

4.3

4.5

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2380

21849

1.53

15.78

6.1

5.6

mmol/mol

39.1

39.5

0.74

2231

20294

(3026493) Urate [Moles/volume] in Serum or Plasma

800

6088

1.44

15.69

2.4

2.6

umol/l

3356.1

5011.3

0.67

702

5314

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1275

10520

1.38

15.59

5.5

5.9

mmol/l

1.2

0.38

1132

9542

(3022145) Colonoscopy Study observation

403

2667

1.59

15.46

1.3

—

(3019309) Folate [Moles/volume] in Red Blood Cells

575

4117

1.50

15.42

1.9

1.7

nmol/l

1207.0

1172.7

0.38

411

3132

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1160

9477

1.38

14.84

2.0

pmol/l

99.7

96.2

1.54

560

4887

(3048689) Calprotectin [Mass/mass] in Stool

434

2957

1.55

14.62

2.4

2.3

ug/g

170.3

130.6

0.73

331

2340

(3017732) Neutrophils [#/volume] in Blood

276

1690

1.70

14.35

2.5

3.0

e9/l

3.8

4.0

0.94

199

1347

(3036481) Cortisol [Moles/volume] in Serum or Plasma

340

2206

1.61

14.10

2.1

nmol/l

363.3

370.1

0.30

314

2015

(3024561) Albumin [Mass/volume] in Serum or Plasma

1217

10096

1.36

13.82

4.4

4.8

g/l

35.9

35.7

0.86

1122

9415

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

161

847

1.95

13.76

2.3

1.9

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

2680

25480

1.82

13.69

17.2

15.8

umol/l

77.0

75.4

1.51

2680

25470

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

700

5316

1.42

13.56

1.6

1.8

mg/l

1.0

1.1

0.91

517

4050

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2571

24187

1.62

13.49

5.4

4.8

mmol/l

2.8

0.19

2386

22377

(3000963) Hemoglobin [Mass/volume] in Blood

2776

26744

2.29

13.16

23.5

20.2

g/l

135.8

135.1

2.17

2750

26394

(3024731) MCV [Entitic volume]

2775

26732

2.28

13.13

23.3

20.0

90.9

91.0

0.05

2746

26384

(3015171) Extractable nuclear Ab [Units/volume] in Serum

176

969

1.87

13.12

1.2

1.3

u/ml

0.2

1.2

1.61

(3003327) Ova and parasites identified in Stool by Light microscopy

146

755

1.98

13.12

1.9

1.7

—

(3035941) MCH [Entitic mass]

2775

26734

2.28

13.10

23.2

20.0

30.3

0.03

2746

26383

(3007461) Platelets [#/volume] in Blood

2774

26721

2.27

13.09

23.4

20.1

e9/l

253.3

253.9

0.21

2735

26081

(3026361) Erythrocytes [#/volume] in Blood

2775

26736

2.28

13.06

23.4

20.1

e12/l

4.5

1.27

2733

26030

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

592

4389

1.44

13.03

1.6

1.5

—

(3010813) Leukocytes [#/volume] in Blood

2775

26740

2.27

12.98

23.4

20.1

e9/l

6.6

6.7

0.36

2733

26032

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2684

25576

1.80

12.94

11.5

10.3

u/l

25.7

25.9

0.25

2611

24742

(3013826) Glucose [Moles/volume] in Serum or Plasma

1581

13725

1.34

12.92

4.4

4.7

mmol/l

6.5

6.7

3.55

1470

12817

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

413

2.32

12.81

2.0

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2445

22800

1.50

12.75

4.3

3.9

mmol/l

1.3

0.69

2246

20977

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2518

23631

1.55

12.69

4.9

4.3

mmol/l

1.5

1.79

2332

21878

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2531

23795

1.55

12.49

4.9

4.3

mmol/l

4.7

0.16

2359

22156

(3000494) Fungus identified in Specimen by Culture

399

2769

1.51

12.22

1.6

1.4

—

(44813793)

153

3.17

12.20

1.1

1.0

—

(36660697) Celiac disease serology panel - Serum

290

1875

1.61

12.16

1.2

—

(3023419) Bacteria identified in Sputum by Culture

278

2.56

11.90

2.6

2.4

—

(3007853) Bacteria identified in Skin by Aerobe culture

386

2700

1.50

11.35

2.1

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1752

15584

1.32

11.34

3.2

3.0

—

(3026389) Candida sp identified in Specimen by Organism specific culture

316

2.41

11.27

1.5

1.3

—

(3013512) EKG study

831

6703

1.34

10.65

4.5

3.7

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

285

2.42

10.36

2.3

mg/l

19.5

24.8

0.53

(3000492) Spirometry study

326

2254

1.50

10.10

1.6

1.4

—

(3025941) Bacteria identified in Stool by Culture

217

1372

1.63

9.96

1.3

1.2

—

(3032080) INR in Blood by Coagulation assay

1087

9176

1.30

9.87

8.8

8.9

inr

1.2

0.12

313

2688

(40768804) Tissue Pathology biopsy report

1163

9916

1.29

9.74

2.3

2.1

—

(3045424) Erythrocytes [Presence] in Urine

426

2.10

9.55

1.5

1.6

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

161

2.82

9.43

1.3

1.2

—

(40768797) Stomach Pathology biopsy report

452

3370

1.41

9.38

1.3

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

164

2.77

9.13

1.3

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

779

6345

1.31

9.06

3.5

3.2

—

(4062490)

219

2.49

8.88

1.8

1.4

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

394

2903

1.41

8.72

5.1

4.4

33.2

32.6

0.58

261

1977

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1772

16054

1.27

8.64

3.4

3.1

u/l

45.3

46.6

0.24

1629

15033

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

731

5952

1.31

8.43

2.4

2.2

mg/l

3.1

2.9

0.90

630

5092

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.40

8.35

4.4

4.3

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

214

2.46

8.31

1.7

1.4

g/l

2.9

0.15

148

(3027135) IgG subclass 1 [Mass/volume] in Serum

214

2.46

8.31

1.7

1.4

g/l

6.3

6.8

0.67

148

(3024139) IgG subclass 3 [Mass/volume] in Serum

214

2.46

8.31

1.7

1.4

g/l

0.3

0.4

0.23

147

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

129

746

1.76

8.28

1.7

g/l

1.2

0.60

120

705

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

524

1.90

8.10

1.4

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

950

8036

1.27

8.07

2.9

3.4

mmol/l

2.3

2.4

1.97

799

7075

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

124

716

1.77

8.01

1.7

g/l

0.2

0.41

115

676

(3022948) Iron [Moles/volume] in Serum or Plasma

470

3614

1.36

8.00

2.5

umol/l

13.5

13.4

0.11

428

3342

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

3.36

7.93

1.2

—

(3005719) IgG [Mass/volume] in Serum or Plasma

257

1786

1.48

7.75

2.6

2.7

g/l

10.1

10.5

0.90

234

1622

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

619

4979

1.31

7.72

1.7

pmol/l

52465927.5

32236800.7

0.33

507

4163

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

405

3066

1.37

7.59

2.6

23.0

23.4

0.22

331

2628

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

131

781

1.71

7.58

1.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

115

662

1.77

7.53

1.4

1.3

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

424

1.96

7.51

1.1

u/ml

0.3

1.5

1.98

168

(3000850) Epithelial cells [#/volume] in Urine

602

4841

1.31

7.50

2.6

2.5

e6/l

4.3

6.1

4.04

521

4226

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

129

770

1.71

7.43

1.7

1.5

titre

52.5

288.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

195

1290

1.55

7.43

1.1

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

226

1546

1.50

7.37

1.3

au/ml

95.5

49.2

—

(3021960) Folate [Moles/volume] in Serum or Plasma

659

5376

1.29

7.35

1.5

nmol/l

20.6

20.7

0.06

556

4589

(3022217) INR in Platelet poor plasma by Coagulation assay

376

2829

1.38

7.31

28.3

23.9

inr

1.4

1.3

0.55

416

(3000034) Microalbumin [Mass/volume] in Urine

205

2.36

7.13

3.8

3.1

mg/l

166.7

36.6

0.59

150

(3011397) Hemoglobin [Presence] in Urine by Test strip

670

5501

1.28

7.08

4.1

3.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

267

1908

1.44

6.98

2.5

2.6

ml/min/173m2

72.9

67.7

1.31

107

758

(3024980) IgG subclass 4 [Mass/volume] in Serum

359

2.00

6.95

2.0

1.6

g/l

0.8

0.02

271

(3026008) Bacteria identified in Urine by Culture

831

7019

1.26

6.93

3.2

3.0

—

(3044889) 12 lead EKG panel

1816

16703

1.24

6.84

4.2

3.6

—

(3025159) Blasts/100 leukocytes in Blood

251

1780

1.45

6.83

4.5

4.3

0.0

0.4

0.87

440

(3019225) pH of Specimen

318

2355

1.39

6.79

4.7

4.2

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

241

1699

1.46

6.77

2.6

2.4

au/ml

29.3

21.9

—

(3020874) Milk IgE Ab [Units/volume] in Serum

121

2.75

6.70

1.0

u/ml

0.3

2.8

0.70

(40761535) Cells panel - Urine sediment

269

1948

1.42

6.54

4.0

3.5

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

424

3308

1.33

6.49

2.6

2.5

g/l

2.4

2.3

0.41

387

3059

(3023430) Cat dander IgE Ab [Units/volume] in Serum

274

2.10

6.41

1.1

u/ml

7.7

4.9

0.22

113

(3014133) Dog dander IgE Ab [Units/volume] in Serum

303

2.04

6.30

1.1

u/ml

3.5

0.02

115

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

3.26

6.27

1.3

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

366

1.94

6.26

1.4

1.3

—

(3002179) Metamyelocytes/100 leukocytes in Blood

251

1814

1.42

6.18

4.1

3.9

0.8

0.6

0.36

405

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

108

648

1.69

6.16

1.2

1.1

—

(3017181) Myelocytes/100 leukocytes in Blood

271

1987

1.40

6.14

4.4

4.1

0.7

0.9

1.15

566

(40768443) Skin Pathology biopsy report

154

1010

1.55

6.14

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

259

1886

1.41

6.11

4.4

4.2

0.1

0.78

519

(4094501)

107

644

1.69

6.04

1.2

1.1

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

105

629

1.69

6.03

1.3

u/l

12.0

11.3

0.18

513

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

221

1572

1.44

5.94

3.1

3.3

pmol/l

4.4

4.5

1.18

195

1398

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

242

1753

1.42

5.89

1.3

1.2

iu/ml

166.1

152.1

0.21

678

(3010726) Horse dander IgE Ab [Units/volume] in Serum

347

1.92

5.84

1.1

u/ml

2.2

2.9

0.17

(3019060) Gas panel - Arterial blood

211

1496

1.44

5.78

3.9

5.4

—

(3004616) Nuclear Ab [Presence] in Serum

314

1.96

5.74

1.4

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

555

1.72

5.71

1.9

1.7

nmol/l

40.8

40.2

0.10

537

(3028026) IgM [Mass/volume] in Serum or Plasma

200

1407

1.45

5.71

1.9

1.8

g/l

1.2

1.4

0.99

186

1274

(3008152) Bicarbonate [Moles/volume] in Arterial blood

201

1416

1.45

5.70

5.1

7.5

mmol/l

24.5

0.01

189

1314

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2373

22650

1.28

5.69

13.8

12.5

ml/min/173m2

81.4

82.2

1.08

1941

18666

(3024522) Salmonella sp identified in Specimen by Organism specific culture

298

1.97

5.50

1.4

1.5

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

203

1444

1.44

5.47

2.5

2.1

nmol/l

12.5

12.4

0.04

186

1278

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

299

1.96

5.45

1.4

1.5

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

110

687

1.63

5.42

1.7

1.4

ug/g

284.4

288.6

0.08

387

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

723

6154

1.23

5.41

5.6

4.9

ug/l

2.3

2.9

1.35

654

5508

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

137

904

1.54

5.35

1.4

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

904

7882

1.21

5.33

3.3

3.2

u/l

29.1

33.3

2.84

853

7496

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

295

1.95

5.31

1.5

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

354

1.86

5.20

1.4

1.2

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.89

5.19

2.8

2.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

2310

22042

1.25

5.14

15.4

14.5

40.0

39.7

0.51

1622

16099

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

363

1.84

5.13

1.2

1.1

—

(3042936) Bacteria identified in Isolate by Culture

406

3253

1.29

5.08

2.1

2.0

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

112

719

1.58

4.96

2.6

2.8

—

(3008898) HLA-B27 [Presence]

129

861

1.52

4.82

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

271

1.94

4.78

1.8

1.6

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

222

1646

1.38

4.75

1.2

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

395

1.77

4.73

2.0

1.8

pmol/l

203.8

200.0

0.11

374

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

294

1.89

4.70

1.5

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

294

1.89

4.70

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

446

3651

1.26

4.68

1.9

1.8

—

(3018418) pH of Serum or Plasma

791

6881

1.21

4.67

3.9

4.0

7.4

0.06

141

1301

(3005988) Vibrio sp identified in Specimen by Organism specific culture

295

1.88

4.65

1.5

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

361

1.79

4.62

1.1

u/ml

0.5

1.6

1.14

152

(3003888) Timothy IgE Ab [Units/volume] in Serum

371

1.77

4.52

1.1

u/ml

3.3

5.1

0.52

188

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

224

1679

1.36

4.49

1.6

1.7

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

103

665

1.57

4.48

1.0

1.1

u/ml

4.0

4.6

0.07

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

516

4315

1.24

4.48

1.6

1.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

244

1856

1.34

4.44

2.7

2.9

ng/l

199.1

185.7

0.18

224

1683

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

148

1036

1.45

4.40

2.7

1.9

u/l

38.7

38.9

0.05

136

923

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

128

874

1.49

4.32

3.8

mmol/l

25.1

24.9

0.31

119

817

(3014599) Egg white IgE Ab [Units/volume] in Serum

119

2.37

4.32

1.0

u/ml

0.4

1.0

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

264

1.87

4.13

2.0

1.9

umol/l

7.3

5.4

0.41

179

(3030981) Hyaline casts [#/volume] in Urine by Automated count

160

1156

1.41

4.03

3.3

2.8

e6/l

0.1

0.3

2.32

154

1121

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

253

1.87

3.98

1.1

u/ml

0.1

0.4

1.40

(3026782) Osmolality of Urine

530

4498

1.22

3.97

3.2

2.6

mosm/kgh2o

522.8

542.2

1.23

444

3822

(3000093) Morphology [Interpretation] in Blood Narrative

198

1.98

3.92

1.2

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

365

1.71

3.92

1.4

u/l

27.8

28.1

0.02

300

(3015076) Soybean IgE Ab [Units/volume] in Serum

107

2.35

3.83

1.0

u/ml

0.1

4.8

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

180

1339

1.37

3.82

3.7

3.5

mmol/l

1.6

1.8

0.23

134

1008

(3022313) Gas panel - Capillary blood

142

1015

1.42

3.81

3.7

3.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

334

2708

1.26

3.80

1.5

1.7

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

176

1306

1.37

3.79

1.7

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

165

1217

1.38

3.70

2.6

2.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

2.70

3.65

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

132

940

1.42

3.63

1.6

—

(3039000) Anion gap in Blood

515

1.57

3.60

4.7

8.8

mmol/l

11.1

11.3

0.19

458

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

230

1792

1.31

3.59

3.7

3.8

ng/l

83.0

86.8

0.28

199

1566

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

572

4937

1.20

3.58

5.1

4.3

21.3

21.4

0.05

275

2377

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

669

1.50

3.57

1.3

1.2

u/ml

5.3

8.4

0.36

117

(3018572) Chloride [Moles/volume] in Blood

516

1.57

3.57

4.7

8.8

mmol/l

105.7

105.1

0.51

459

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

394

1.64

3.46

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

659

1.49

3.43

1.3

1.2

u/ml

1.4

3.1

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

530

1.54

3.41

1.2

u/ml

53.7

41.6

—

(3032057) Clostridioides difficile [Presence] in Stool

2.99

3.41

2.1

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

108

751

1.46

3.40

1.7

1.6

iu/ml

1.7

9.0

0.38

135

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

308

2511

1.25

3.36

1.8

1.7

—

(3038026) Centromere Ab [Units/volume] in Serum

210

1.87

3.35

1.3

1.2

—

55.6

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

134

2.10

3.33

1.5

1.3

titre

24.0

56.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1224

11277

1.15

3.31

4.0

—

(3000475) Leukocytes [#/volume] in Synovial fluid

550

1.52

3.31

1.7

e6/l

10012.1

12531.3

0.41

404

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

514

4425

1.20

3.30

3.8

3.6

ng/l

195.7

402.9

2.18

391

3302

(3009343) pH of Capillary blood

182

1390

1.33

3.29

3.8

3.6

7.4

1.45

171

(3045414) Leukocytes [Presence] in Urine

150

1114

1.37

3.26

1.9

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

184

1410

1.33

3.25

3.8

3.6

kpa

5.1

5.2

0.21

172

1317

(4024509)

227

1.82

3.24

1.4

1.6

—

(3042631) Mycobacterium sp identified in Specimen

294

1.71

3.23

3.1

2.7

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

207

1.85

3.17

1.3

1.2

—

51.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

286

2331

1.25

3.14

1.4

—

(3047181) Lactate [Moles/volume] in Blood

103

723

1.44

3.11

4.5

7.4

mmol/l

1.3

0.01

627

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

307

2528

1.24

3.08

1.8

1.7

—

(3002582) Erythrocytes [#/volume] in Urine

774

6934

1.16

3.04

3.4

3.1

e6/l

61.2

87.9

0.40

617

5304

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

127

2.06

2.96

1.3

pmol/l

38.7

54.7

0.42

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

524

1.50

2.95

1.3

1.2

—

10.9

—

(3023368) Bacteria identified in Blood by Culture

680

6058

1.16

2.86

3.8

4.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

441

3793

1.19

2.85

3.2

3.4

mmol/l

0.8

0.81

409

3558

(3018095) Leukocytes [#/volume] in Urine

903

8221

1.14

2.80

3.9

3.6

e6/l

65.9

99.4

1.18

677

5737

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

2.23

2.80

1.8

1.7

—

(3022621) pH of Urine by Test strip

196

1550

1.28

2.79

3.3

2.9

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

180

1.84

2.77

1.3

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

180

1.84

2.77

1.3

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

180

1.84

2.77

1.3

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

193

1527

1.28

2.74

2.0

2.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

642

1.43

2.72

3.0

2.0

mg/l

10.2

11.6

0.97

591

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

285

2366

1.23

2.67

2.2

1.9

—

(3044941) Cell count panel - Synovial fluid

361

1.56

2.59

1.2

1.5

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

489

4284

1.17

2.55

2.6

3.0

mmol/l

2.4

1.86

428

3782

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.17

2.51

1.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

188

1.76

2.45

1.0

1.1

—

(4015189)

2.46

2.44

1.6

2.3

—

(3003338) MCHC [Mass/volume]

2124

20501

1.14

2.44

18.7

17.5

g/l

332.4

332.3

0.39

2105

20368

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.56

2.44

1.3

1.5

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

2.95

2.41

1.1

—

(36304419) Bacteria [Presence] in Urine

688

6210

1.14

2.38

3.1

3.0

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

2.76

2.37

1.3

1.1

94.2

96.1

0.09

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.76

2.37

1.3

1.1

—

(3027945) Reticulocytes/100 erythrocytes in Blood

297

2511

1.20

2.34

2.3

2.7

1.7

1.8

0.65

254

2236

(3003396) Base excess in Arterial blood by calculation

304

2576

1.20

2.34

5.5

7.8

mmol/l

1.2

1.1

0.44

229

2006

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

120

912

1.33

2.33

4.1

6.2

1.9

1.6

1.51

113

845

(3016502) Oxygen saturation in Arterial blood

274

2301

1.21

2.32

5.7

8.3

96.5

95.7

2.51

263

2216

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

300

2546

1.20

2.27

2.9

4.4

u/l

243.0

247.1

0.15

274

2406

(3023323) Follitropin [Units/volume] in Serum or Plasma

153

1207

1.28

2.27

1.3

1.4

iu/l

26.8

29.3

0.45

135

1032

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

178

1.75

2.26

1.3

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

178

1.75

2.26

1.3

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

178

1.75

2.26

1.3

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

3.11

2.22

1.1

—

(40758558) Short blood count panel - Blood

673

6093

1.14

2.21

5.8

6.7

—

(3028707) Methadone [Presence] in Urine by Screen method

360

1.51

2.20

1.6

2.3

—

(4198724)

2.13

2.18

1.7

1.5

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

386

1.49

2.16

1.3

1.5

nmol/l

0.2

0.3

2.60

298

(3007930) Methemoglobin/Hemoglobin.total in Blood

118

906

1.32

2.16

4.1

6.3

0.9

0.81

111

843

(3023520) Reticulocytes [#/volume] in Blood

224

1860

1.22

2.14

2.2

2.7

e9/l

72.1

71.0

0.16

178

1422

(3023511) Choriogonadotropin [Units/volume] in Urine

437

1.45

2.12

1.4

1.2

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

275

1.57

2.11

1.4

1.6

58.6

59.5

0.05

176

(3010144) Erythrocytes [#/volume] in Synovial fluid

228

1.63

2.11

1.2

1.4

e6/l

199144.6

62085.4

0.32

160

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

705

6426

1.13

2.07

1.7

1.6

mmol/l

1.3

1.4

0.73

596

5441

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

408

1.46

2.03

1.5

1.4

—

(3016038) Potassium [Moles/volume] in Urine

147

1.78

2.02

1.5

1.1

mmol/l

33.7

35.6

0.17

130

(3044927) Protein electrophoresis panel - Urine

231

1.61

2.02

1.4

1.2

—

(3027801) Oxygen [Partial pressure] in Arterial blood

301

2586

1.18

2.01

5.5

7.8

kpa

12.0

12.4

0.72

286

2463

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

301

2586

1.18

2.01

5.5

7.8

kpa

5.0

5.1

1.17

287

2464

(3044640) Blood type and Crossmatch panel - Blood

821

7567

1.12

1.99

2.3

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

639

1.36

1.98

1.5

1.8

—

(3017704) Immunofixation for Urine

126

1.83

1.98

1.2

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

126

1.83

1.98

1.0

1.2

u/l

13.1

23.3

1.50

(4133840)

2.29

1.97

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

2.19

1.94

1.3

1.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

252

2142

1.19

1.91

5.9

8.7

g/l

126.2

121.3

3.39

243

2058

(3037121) Protein [Mass/volume] in Urine

105

809

1.31

1.91

3.3

3.2

g/l

0.3

0.21

331

(3051593) INR in Capillary blood by Coagulation assay

1.96

1.90

2.9

11.0

—

(3030467) Casts [#/volume] in Urine by Automated count

694

6356

1.12

1.87

3.2

3.0

e6/l

0.2

0.4

4.66

544

4769

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

2.86

1.86

1.1

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

214

1.60

1.82

1.3

1.4

29.7

34.4

0.39

131

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

120

948

1.28

1.82

1.6

1.7

mg/l

3.9

3.8

0.01

670

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

246

1.55

1.81

1.1

1.2

u/l

55.8

63.6

0.41

171

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

401

3555

1.15

1.81

3.5

3.0

ug/l

0.7

0.13

264

2324

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

147

1192

1.25

1.79

2.0

1.8

—

(3020630) Protein [Mass/volume] in Serum or Plasma

219

1851

1.20

1.78

2.0

2.8

g/l

66.5

66.4

0.05

194

1696

(1002224) Polysomnography panel

126

1007

1.26

1.75

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.03

1.75

1.1

1.3

104.7

89.6

—

(3001556) Androgen free Index in Serum or Plasma

3.34

1.74

1.3

1.2

—

(3020891) Body temperature

114

902

1.27

1.72

4.2

4.5

—

(3003181) Sodium [Moles/volume] in Urine

407

1.41

1.70

1.4

1.3

mmol/l

64.7

61.7

0.23

327

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

2.30

1.70

2.4

2.2

umol/l

7.6

18.9

4.63

(3017143) Hepatitis C virus Ab [Presence] in Serum

313

2741

1.16

1.68

1.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

222

1892

1.19

1.66

1.9

2.4

ug/l

4.9

6.8

1.77

190

1680

(3004451) EKG impression Narrative

112

1.79

1.64

1.3

—

(3009508) Creatinine [Moles/volume] in Urine

781

7251

1.11

1.63

3.2

mmol/l

7.5

0.12

663

6121

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

105

1.81

1.63

1.1

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

105

831

1.27

1.60

1.8

1.6

mu/l

272.0

308.6

1.12

749

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

113

1.78

1.60

1.3

2.2

159.8

144.6

0.40

107

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

769

1.28

1.60

2.0

2.4

ug/l

175.1

418.7

2.48

723

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

716

1.29

1.60

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

725

1.29

1.59

1.2

—

(4027681)

151

1.66

1.59

1.2

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

116

930

1.26

1.59

1.6

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.95

1.59

1.1

92.5

90.2

—

(3011288) Drugs identified in Urine by Screen method

559

1.33

1.59

1.7

2.5

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

471

4261

1.13

1.57

1.9

1.8

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

719

1.29

1.56

1.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

122

1.73

1.54

1.2

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

393

3525

1.13

1.51

1.8

2.2

29.2

29.7

1.12

378

3418

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

193

1.56

1.51

1.1

mg/l

225.5

278.0

0.90

168

(3051387) C reactive protein [Mass/volume] in Capillary blood

512

1.34

1.50

3.5

3.7

mg/l

21.7

25.9

0.35

316

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.07

1.49

1.6

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

101

1.79

1.48

1.6

1.8

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

359

1.40

1.48

1.6

1.4

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.50

1.45

1.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

299

2642

1.15

1.44

2.4

2.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

152

1274

1.20

1.41

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

606

1.30

1.40

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

197

1.53

1.40

3.7

3.2

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.61

1.36

1.7

1.9

umol/l

40.2

47.0

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

145

1214

1.20

1.36

6.6

11.1

—

(3007566) Smooth muscle Ab [Titer] in Serum

662

1.28

1.36

1.2

titre

128.9

93.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

636

1.28

1.36

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

248

1.46

1.35

4.5

u/ml

13.6

84.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

1.87

1.34

1.1

1.2

113.1

109.4

0.13

(3022689) Creatine [Moles/volume] in Urine

1.92

1.33

1.6

—

(3037756) Immunofixation for Serum or Plasma

471

1.32

1.3

1.7

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

320

2860

1.13

1.32

1.9

1.7

1.4

1.5

1.97

275

2513

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

200

1.51

1.32

1.2

1.1

mg/l

30.9

42.0

1.15

166

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

2.50

1.30

3.2

2.3

mg/l

2.3

1.3

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

2.05

1.26

1.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

286

1.40

1.25

1.1

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

476

1.31

1.25

3.4

3.6

53.8

57.3

1.72

476

(40757373) Influenza virus identified in Isolate

2.04

1.22

1.2

1.7

—

(3018405) Lactate [Moles/volume] in Arterial blood

809

1.23

1.21

3.8

3.9

mmol/l

1.3

1.4

0.43

795

(3048929) Epstein Barr virus Ab [Presence] in Serum

719

1.25

1.21

1.1

1.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

314

1.38

1.20

1.6

1.5

—

(3016879) Cocaine [Presence] in Urine

765

1.24

1.20

1.5

1.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

418

1.32

1.19

3.0

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

727

0.77

1.19

1.3

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

1.75

1.19

2.7

umol/l

25.0

29.8

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

102

839

1.22

1.18

2.2

2.0

u/l

7962.0

4054.9

0.58

327

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

165

1.52

1.17

1.3

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

133

1.58

1.17

1.3

1.2

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

190

1.48

1.16

1.1

—

(3027008) Opiates [Presence] in Urine

101

832

1.22

1.16

1.5

1.8

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

174

1.50

1.15

1.2

1.4

promille

1.4

1.3

0.19

138

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

0.00

1.15

0.0

3.4

—

41.4

—

(3027944) Amphetamines [Presence] in Urine

816

1.22

1.13

1.5

1.8

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.96

1.11

1.0

1.4

—

131.3

—

(3028300) Cannabinoids [Presence] in Urine

101

837

1.21

1.10

1.5

1.8

—

(3049717) Cytology report of Urine Cyto stain

100

829

1.21

1.09

3.0

2.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.19

1.08

1.0

—

(3035637) Corticotropin [Mass/volume] in Plasma

279

1.37

1.05

1.5

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

253

0.63

1.04

1.8

ug/l

11.8

19.4

6.44

247

(3003740) Influenza virus B Ag [Presence] in Specimen

384

1.31

1.04

1.0

1.1

—

(3021589) Normoblasts [#/volume] in Blood

1100

10540

1.07

1.03

10.1

9.2

e9/l

0.0

2.39

938

8605

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

2.06

1.03

1.7

1.3

nmol/l

7.6

1023082.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

122

1.56

1.02

3.2

2.6

u/ml

657.5

1140.3

1.06

122

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

247

2214

1.13

1.02

2.0

2.2

g/l

0.2

1.24

230

2072

(3000330) Specific gravity of Urine by Test strip

1158

0.83

1.02

4.1

3.3

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

188

1.44

1.01

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

386

1.30

1.01

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

828

1.20

1.00

1.5

1.8

—

(3021788) Differential panel - Synovial fluid

404

1.29

1.00

1.4

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

172

1507

1.15

1.00

2.2

1.9

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

2.00

1.00

1.0

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

378

1.30

1.00

1.3

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

131

1.53

0.99

1.2

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

476

1.27

0.99

2.3

g/l

134.5

129.9

0.67

352

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

0.00

0.97

0.0

1.7

—

7.7

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

877

1.19

0.97

2.1

2.6

g/l

7.2

7.3

0.30

663

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

877

1.19

0.97

2.1

2.6

g/l

3.9

3.8

0.46

631

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

104

877

1.19

0.97

2.1

2.6

—

(3032773) Endomysium IgG Ab [Titer] in Serum

198

1.42

0.97

1.1

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

140

1.50

0.97

1.0

1.3

—

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

0.00

0.97

0.0

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

214

1908

1.13

0.97

3.6

mmol/l

1.2

0.05

182

1657

(40767503) Oxygen content in Capillary blood by calculation

460

1.27

0.96

2.7

2.4

16.5

16.2

0.21

228

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

1.85

0.96

1.0

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

174

0.57

0.96

1.1

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

198

0.60

0.95

1.0

1.5

umol/l

10.5

12.3

0.70

187

(3014051) Protein [Presence] in Urine by Test strip

568

0.77

0.94

2.7

2.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.77

0.94

1.1

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1.65

0.94

3.5

3.1

mg/l

8.2

7.6

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

260

1.35

0.93

1.3

1.7

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

286

1.33

0.93

1.2

1.4

pmol/l

300.4

299.5

0.01

223

(44806118)

269

1.34

0.92

1.6

1.4

—

(44790049)

269

1.34

0.92

1.6

1.4

—

(44790048)

269

1.34

0.92

1.6

1.4

—

(44790047)

269

1.34

0.92

1.6

1.4

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

1.82

0.92

5.8

8.1

—

(3002385) Erythrocyte distribution width [Ratio]

2044

20038

1.07

0.91

18.0

16.5

13.6

13.7

1.33

2016

19613

(3011648) Oxygen content in Venous blood

182

0.60

0.89

1.5

2.3

10.7

11.0

0.07

182

(3052592) Norovirus Ag [Presence] in Stool

1.86

0.87

1.3

1.5

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

153

1.44

0.85

1.5

1.6

u/l

9.2

6.8

0.28

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

317

1.30

0.85

1.2

1.3

mmol/l

7.5

0.02

229

(3027231) Wheat IgE Ab [Units/volume] in Serum

1.78

0.84

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

162

1.42

0.84

1.6

2.3

—

(3020779) Urea [Moles/volume] in Serum or Plasma

220

1986

1.12

0.84

7.2

7.9

mmol/l

9.7

9.5

0.13

209

1902

(4281824)

285

0.70

0.83

1.1

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

516

1.23

0.82

1.3

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

121

1.49

0.82

1.3

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

600

0.80

0.82

1.5

1.7

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.69

0.82

1.5

3.2

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

1.69

0.82

1.5

3.2

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

337

1.28

0.81

1.7

1.9

—

3.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

155

1.42

0.81

1.1

u/l

0.9

1.1

2.63

(4146454)

250

1.32

0.80

2.3

2.7

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

822

1.17

0.79

2.1

2.6

g/l

2.9

3.1

0.74

647

(3014891) Appearance of Pleural fluid

1.82

0.79

3.0

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.79

0.0

2.0

—

(3012516) Albumin [Mass/volume] in Urine

710

6763

1.07

0.78

3.2

3.3

mg/l

714.8

347.3

0.80

414

4203

(3020717) Zinc [Moles/volume] in Serum or Plasma

131

1.45

0.78

1.6

1.4

umol/l

16.5

26.1

1.00

123

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

313

1.28

0.78

1.5

—

(3044242) Glucose [Moles/volume] in Arterial blood

124

0.56

0.77

1.0

2.3

—

(3024263) Appearance of Synovial fluid

115

1.48

0.76

1.4

1.8

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

157

1.40

0.76

1.1

1.2

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

114

994

1.15

0.76

1.5

1.9

g/l

1.5

0.20

858

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

109

948

1.16

0.75

2.0

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

209

1.34

0.75

2.0

2.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

1.57

0.75

1.1

1.2

116.0

109.4

0.28

(3013293) Extractable nuclear Ab [Presence] in Serum

1.84

0.73

1.1

1.8

—

(3000012) Reticulocyte production index

108

1.48

0.73

1.1

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

171

0.64

0.72

1.5

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

445

0.78

0.71

1.4

1.5

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

117

1.46

0.71

1.7

—

(3003694) ABO and Rh group [Type] in Blood

637

6683

0.94

0.71

1.4

—

(3021901) Oxygen saturation in Capillary blood

399

1.23

0.70

2.7

2.8

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.71

0.70

1.0

1.3

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

546

1.19

0.69

1.5

1.4

e6/l

28.5

27.7

0.01

416

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.85

0.68

1.0

1.7

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

547

1.19

0.68

1.6

1.5

e6/l

420.0

1562.1

1.15

443

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

102

1.47

0.67

1.1

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

548

1.19

0.67

1.6

1.7

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

223

1.30

0.66

3.0

2.5

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.53

0.66

1.0

1.1

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

1.51

0.66

1.5

2.3

170.3

156.2

0.22

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

197

1.32

0.65

1.5

1.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

378

3549

1.08

0.65

1.5

1.6

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

103

1.46

0.65

1.2

1.1

miu/ml

1159.4

1532.1

0.73

103

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

858

1.15

0.65

1.9

1.8

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

242

1.28

0.64

1.4

1.8

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.48

0.64

1.3

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.48

0.64

1.3

1.5

—

(3032868) Hemoglobin electrophoresis panel in Blood

1.73

0.64

1.4

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.73

0.64

1.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

350

1.23

0.63

1.0

1.1

u/ml

4.7

2.3

0.37

155

(3045788) Cell count panel - Pleural fluid

212

0.71

0.63

1.6

1.4

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

627

1.17

0.62

1.4

1.3

mg/l

392.4

524.8

5.98

595

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

104

1.44

0.62

1.5

2.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

104

1.44

0.62

1.5

2.1

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

461

1.20

0.62

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

434

0.80

0.61

1.3

1.4

—

(40768795) Lymph node Pathology biopsy report

233

0.73

0.61

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.60

0.0

1.1

—

(44786800) Granulocytes/100 leukocytes in Body fluid

0.00

0.60

0.0

1.5

—

25.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

105

1.43

0.60

1.9

2.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

227

1.28

0.60

1.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

324

3039

1.07

0.59

6.0

5.9

mmol/l

1.0

0.44

293

2820

(3005033) Fetal Nuchal fold Thickness US

432

0.81

0.59

1.3

1.4

—

(3011412) CD3 cells [#/volume] in Blood

219

1.28

0.58

1.2

2.5

e9/l

1.1

0.11

131

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.58

0.0

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.58

0.0

1.0

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

223

2409

0.92

0.58

3.5

4.1

ug/l

7.0

20.0

1.88

172

1939

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

105

1179

0.89

0.58

7.8

9.9

mmol/l

24.5

24.3

0.24

1110

(3014271) Vancomycin [Susceptibility]

106

1.42

0.57

2.8

2.7

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

116

0.60

0.57

1.0

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1041

0.88

0.57

4.9

3.9

mmol/l

24.1

0.01

935

(3042111) Morphology [Interpretation] in Bone marrow Narrative

401

1.20

0.57

1.3

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

661

1.15

0.57

2.3

2.6

g/l

0.0

0.03

613

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.67

0.56

4.3

8.8

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

634

1.16

0.56

2.1

1.6

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

338

1.22

0.56

3.6

5.6

umol/l

345.4

369.4

0.46

288

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

407

0.81

0.56

1.1

1.0

—

(3048879) Bone marrow aspiration report

1.54

0.55

1.0

2.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

133

1.36

0.55

1.4

1.9

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

133

1.36

0.55

1.4

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

133

1.36

0.55

1.4

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

133

1.36

0.55

1.4

1.9

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

570

1.16

0.55

1.7

1.6

—

(3035880) pH of Pleural fluid

122

0.65

0.54

1.5

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

312

1.22

0.54

1.2

1.3

—

(4211845)

116

1.38

0.54

3.1

3.2

—

(3006245) CD3-CD19+ cells/100 cells in Blood

1.47

0.54

1.2

2.6

9.3

8.6

0.12

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.45

0.53

1.2

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

360

1.20

0.51

2.6

1.8

mmol/l

1.5

1.7

0.91

354

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

210

2259

0.92

0.51

2.2

2.4

u/l

30.0

60.6

0.83

179

1936

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

214

0.75

0.51

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

215

1.26

0.51

1.4

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

215

1.26

0.51

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

215

1.26

0.51

1.4

1.7

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.47

0.50

1.7

1.9

—

(3024869) Neuronal Ab [Presence] in Serum

1.46

0.50

1.2

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

213

0.75

0.50

1.3

1.4

mmol/l

6.9

6.5

0.17

197

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

298

1.21

0.49

1.2

1.3

nmol/l

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

602

5793

1.05

0.49

2.1

2.3

—

(3002619) Bacteria identified in Specimen by Culture

1.56

0.49

2.4

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

110

1.37

0.48

1.1

1.0

—

(3020682) Albumin/Creatinine [Ratio] in Urine

736

7118

1.05

0.48

4.1

4.0

mg/mmol

10.7

9.2

0.26

434

4430

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

110

0.64

0.48

1.1

3.7

—

(3023410) Appearance of Cerebral spinal fluid

244

1.23

0.48

1.5

1.6

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

245

0.77

0.48

1.9

1.7

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

208

1.25

0.48

1.1

1.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

474

0.84

0.47

1.1

1.2

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

447

1.17

0.47

1.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

475

1.16

0.47

4.6

5.4

iu/ml

525.5

685.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

177

0.73

0.47

2.2

1.6

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

560

1.15

0.47

1.4

1.3

mmol/l

3.8

0.03

529

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

1.46

0.46

1.6

2.8

—

(1175426) CD3 cells/100 lymphocytes in Blood

173

1.27

0.46

1.2

2.3

71.8

72.7

0.10

164

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.43

0.46

1.1

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

1.43

0.46

5.6

8.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

147

1.29

0.45

1.2

1.1

—

(3036603) Volume of Urine

165

1.27

0.45

2.0

1.4

2348.7

2070.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

413

1.16

0.44

3.4

3.2

nmol/l

0.9

0.8

0.17

317

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.40

0.44

1.0

1.2

—

(3023183) Ammonium ion [Moles/volume] in Plasma

480

0.85

0.43

2.2

3.1

umol/l

33.0

34.9

0.29

412

(4306422)

377

1.17

0.43

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

1.61

0.43

1.0

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

1.43

0.42

1.0

—

(3013637) Mi-2 Ab [Presence] in Serum

1.40

0.42

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.40

0.42

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.40

0.42

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.40

0.42

1.0

1.1

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

406

3888

1.05

0.41

2.8

2.6

e6/l

0.9

1.2

1.14

257

2200

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.52

0.41

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

826

0.89

0.41

2.5

3.5

u/ml

113.4

5049.7

0.84

700

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

250

0.80

0.41

1.2

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

814

1.11

0.41

2.0

2.6

g/l

10.9

10.2

0.62

696

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.41

0.0

1.1

—

20.8

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

314

1.18

0.41

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

891

1.10

0.40

2.1

2.0

ug/l

1.7

1.6

0.04

794

(3024316) Viscosity of Plasma

0.00

0.40

0.0

1.5

—

1.8

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

0.00

0.40

0.0

1.6

—

15.4

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.40

0.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.40

0.0

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

401

0.85

0.40

1.2

1.1

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.47

0.40

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

625

1.12

0.40

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

455

1.15

0.40

1.5

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

455

1.15

0.40

1.5

1.3

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.40

0.0

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

223

1.21

0.39

3.0

3.4

57.8

56.3

0.12

149

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

0.00

0.39

0.0

1.1

—

40.9

—

(3006462) Nitrate [Presence] in Urine

106

1.32

0.39

3.3

—

(4034850)

789

1.11

0.38

6.6

9.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

151

1.26

0.38

1.1

ratio

1.1

1.0

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

448

1.14

0.38

1.5

1.7

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

401

1.15

0.38

1.2

1.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

289

1.18

0.38

1.1

1.2

—

(3012441) Differential panel - Pleural fluid

225

0.80

0.38

1.6

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

243

1.20

0.37

2.9

4.4

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

1.39

0.37

1.4

1.9

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

754

1.10

0.36

2.2

2.8

g/l

0.5

1.1

1.55

662

(1761482) Bacteria [#/volume] in Urine by Culture

554

1.12

0.36

4.7

4.2

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

1.36

0.36

1.1

2.6

19.8

29.8

3.30

(3000991) Gas panel - Venous blood

174

1852

0.94

0.36

7.1

8.5

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

226

1.20

0.35

1.9

1.6

—

(3024471) HLA-A [Type]

0.66

0.35

1.0

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

423

1.14

0.35

1.5

1.7

—

(40758292) HTLV I+II Ab panel - Serum

1.40

0.35

1.3

1.4

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.36

0.34

1.2

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

172

1.22

0.34

1.2

2.3

11.0

13.8

—

(3015183) Erythrocyte sedimentation rate

127

1.26

0.33

1.3

1.2

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

571

0.89

0.32

1.4

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

370

1.14

0.31

2.2

3.6

0.8

1.4

0.74

293

(3014111) Lactate [Moles/volume] in Serum or Plasma

187

1972

0.94

0.30

5.5

7.1

mmol/l

1.2

1.3

2.09

173

1903

(40768793) Breast Pathology biopsy report

611

1.10

0.29

1.4

1.3

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

250

1.16

0.29

1.0

1.1

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

148

1.22

0.29

1.1

1.0

—

(3016018) Differential panel - Cerebral spinal fluid

260

1.16

0.28

1.4

—

(3002256) Pathology report gross observation

323

3112

1.04

0.28

1.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

238

0.84

0.28

1.9

1.4

e6/l

90740.6

103469.8

0.05

138

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

471

0.89

0.28

2.5

3.6

u/ml

275.6

888.4

0.54

436

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

151

0.79

0.28

2.8

1.8

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

149

1.21

0.27

3.2

1.4

u/l

13.2

13.3

0.03

141

(3019832) Treponema pallidum Ab [Presence] in Serum

224

2142

1.05

0.27

1.7

1.6

—

(3025130) Human papilloma virus identified in Specimen

346

1.13

0.27

2.1

1.8

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

116

0.78

0.27

1.4

2.1

—

182.7

—

(3047189) Immunofixation for 24 hour Urine

119

0.76

0.27

1.1

1.6

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

624

1.09

0.27

1.2

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

635

1.09

0.26

1.7

1.9

iu/l

5.7

4.5

0.21

222

(3024932) HLA-DR beta [Type]

0.69

0.26

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

197

1.17

0.25

1.2

1.1

nmol/l

367.4

384.8

0.15

177

(3004119) Hemoglobin [Mass/volume] in Venous blood

128

1353

0.94

0.24

3.1

g/l

131.9

128.2

1.36

122

1315

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

148

0.81

0.24

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

255

0.86

0.24

1.2

1.4

mosm/kgh2o

276.2

278.5

0.33

195

(3006653) Thiamine [Moles/volume] in Blood

126

0.79

0.24

1.0

1.4

nmol/l

155.1

134.3

—

126

(4035726)

205

2136

0.96

0.23

1.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

322

1.12

0.23

1.6

1.5

—

(40768800) Prostate Pathology biopsy report

389

1.11

0.23

1.2

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

190

0.84

0.23

1.4

1.5

g/l

1.0

0.23

190

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

264

0.87

0.23

2.4

2.5

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

390

1.10

0.22

1.2

u/ml

2.9

4.0

0.28

126

(40768446) Kidney Pathology biopsy report

1.25

0.22

1.5

1.6

—

(3024354) Oxygen [Partial pressure] in Venous blood

172

1646

1.05

0.22

3.2

2.9

kpa

4.3

4.6

1.19

164

1594

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

1.25

0.22

1.0

1.3

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

1.25

0.22

1.0

1.3

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

1.25

0.22

1.0

1.3

—

(3001019) Free T4 and TSH panel - Serum or Plasma

146

1392

1.05

0.22

1.7

—

(3036489) Thrombin time

906

0.94

0.22

1.6

2.1

20.9

21.4

0.45

793

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

228

2198

1.04

0.22

1.6

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

273

0.88

0.21

1.1

1.4

ug/l

1.3

4.1

2.43

238

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.21

0.0

7.7

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.21

0.0

1.3

—

2.6

—

(40760409) HLA-A [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.21

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

4.0

—

(3013862) HLA-DP [Type]

0.00

0.21

0.0

1.0

—

(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid

0.00

0.21

0.0

4.9

—

406.3

—

(40760410) HLA-B [Type] by High resolution

0.00

0.21

0.0

1.0

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.21

0.0

1.0

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.00

0.21

0.0

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

220

0.86

0.21

1.1

1.0

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

0.00

0.21

0.0

1.3

—

3714.7

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

1.6

—

28.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.00

0.21

0.0

4.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.23

0.21

1.3

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

126

1.19

0.21

1.4

1.7

u/field

2.1

3.5

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

145

0.83

0.21

11.2

12.6

nmol/l

484.4

848.6

2.76

139

(3013762) Body weight Measured

0.00

0.21

0.0

1.3

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.21

0.0

13.5

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

0.00

0.21

0.0

1.0

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

383

1.10

0.20

1.2

u/ml

3.3

5.3

0.84

157

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

135

1414

0.95

0.20

3.6

3.4

u/ml

136.6

51.1

0.42

130

1368

(3045142) Bone marrow Pathology biopsy report

282

0.89

0.20

1.2

1.3

—

(3002032) Base excess in Venous blood by calculation

195

2023

0.96

0.19

3.9

3.7

mmol/l

1.6

1.9

0.61

162

1633

(3051651) Icteric interference index of Serum or Plasma

144

0.83

0.19

2.3

3.5

—

(21494755) Public health laboratory ask at order entry panel

226

2336

0.96

0.19

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.22

0.19

1.2

1.0

—

(21494434) Karyotype in Bone marrow

222

1.13

0.19

1.1

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

270

0.89

0.19

1.8

1.4

e6/l

3164.2

2419.3

0.14

195

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

686

1.07

0.18

2.1

2.6

g/l

38.7

37.8

0.73

597

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

137

1312

1.05

0.18

1.5

1.6

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

157

1.15

0.17

1.0

ng/l

826.1

700.6

0.62

102

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

143

1486

0.96

0.16

1.4

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

768

1.06

0.16

1.5

1.3

miu/ml

248.3

217.5

0.29

365

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

1.16

0.16

1.3

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

1.16

0.16

1.3

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

276

2689

1.03

0.16

2.4

2.7

umol/l

7.5

8.1

0.13

241

2351

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

158

1.14

0.16

1.0

ng/l

255.1

315.3

0.78

104

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

224

0.89

0.15

1.2

1.0

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

472

0.93

0.15

1.1

1.2

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

546

1.06

0.15

2.1

2.4

ug/min

32.9

104.0

2.74

330

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

159

1.13

0.15

1.1

1.2

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

482

0.93

0.15

1.5

—

(3028433) Virus identified in Specimen by Culture

1.08

0.14

1.0

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

537

1.06

0.14

1.4

1.6

—

(40768441) Liver Pathology biopsy report

181

0.88

0.14

1.4

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

185

1797

1.03

0.14

1.4

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

160

1.13

0.14

1.0

ng/l

43.1

46.2

0.16

101

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.19

0.14

1.1

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

170

0.88

0.13

1.4

1.6

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

113

1.15

0.13

1.2

1.6

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

138

0.87

0.13

1.3

1.1

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

198

2032

0.97

0.13

3.8

3.7

kpa

5.9

5.8

0.35

189

1970

(3051611) Lipemic interference index of Serum or Plasma

241

0.91

0.12

3.5

3.2

—

(3010421) pH of Blood

610

0.95

0.12

4.0

3.9

7.4

1.48

503

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

313

0.93

0.12

1.7

1.6

—

(21494814) CD8 cells/100 lymphocytes in Specimen

1.16

0.11

1.4

1.9

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

182

1.10

0.11

1.4

2.1

u/field

3.3

2.0

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

134

1.12

0.11

1.1

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

526

0.95

0.11

1.4

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

115

1.13

0.10

2.0

1.7

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

525

0.95

0.10

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

525

0.95

0.10

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

251

1.08

0.10

2.8

2.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

494

0.95

0.10

2.4

2.1

nmol/l

1.3

0.8

0.71

410

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

398

1.06

0.10

1.5

1.8

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

106

1.13

0.09

2.1

2.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

524

0.95

0.09

1.4

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

155

0.90

0.09

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

155

0.90

0.09

1.1

1.0

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.13

0.09

1.4

1.2

g/l

—

0.3

—

(21494890) Protein electrophoresis panel - 24 hour Urine

243

1.07

0.08

1.5

2.2

—

(3008037) Lactate [Moles/volume] in Venous blood

461

0.95

0.08

3.8

3.0

mmol/l

1.3

1.5

1.94

446

(4268621)

263

1.07

0.08

2.4

2.2

—

(3038515) Glucose [Moles/volume] in Venous blood

430

0.95

0.08

4.0

3.1

mmol/l

7.0

7.4

0.68

419

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

0.77

0.08

1.4

1.8

ug/l

1.2

1.9

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

734

0.97

0.08

2.7

3.2

u/ml

0.4

0.37

421

(3012501) Base excess in Blood by calculation

509

1.04

0.08

4.2

4.1

mmol/l

2.5

2.6

0.24

341

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.09

0.08

1.3

1.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

391

1.05

0.08

1.1

iu/ml

4.9

1529.6

—

(3044007) Cell count panel - Peritoneal fluid

1.06

0.08

1.9

2.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

242

2383

1.02

0.08

3.8

3.2

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

127

1.10

0.08

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

0.83

0.07

1.7

1.5

g/l

12.5

13.6

—

(40768806) Pleura Pathology biopsy report

225

0.93

0.07

1.4

1.5

—

(3041806) Other cells [#/volume] in Blood by Manual count

1.07

0.07

2.5

1.6

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.87

0.07

1.0

1.3

ug/l

8.0

8.9

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1013

0.98

0.06

2.3

2.6

0.7

0.34

974

(3004775) Volume in Urine collected for unspecified duration

183

0.93

0.06

1.8

2.3

663.7

632.8

0.12

125

(3016750) Collection duration of Urine

142

0.92

0.06

1.7

2.1

min

500.5

496.9

—

104

(3024928) Oxygen saturation in Venous blood

477

0.96

0.06

2.6

3.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

162

0.93

0.06

1.1

—

(3033658) Prothrombin time (PT) actual/Normal

607

6031

1.01

0.05

3.5

3.8

92.4

91.6

0.31

580

5872

(3034860) Kappa light chains.free [Mass/volume] in Serum

692

1.03

0.05

2.6

3.7

mg/l

59.4

61.4

0.03

571

(3023420) DNA double strand Ab [Units/volume] in Serum

263

0.95

0.05

1.6

1.5

—

25.4

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

425

0.96

0.05

1.1

1.4

u/ml

112.4

120.0

0.21

(40761536) Microorganisms panel - Urine sediment

205

2025

1.01

0.05

4.6

3.8

—

(1761868) Lipid panel - Serum or Plasma

868

8640

1.01

0.05

2.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

110

0.91

0.05

1.1

1.2

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

120

0.92

0.05

1.4

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

120

0.92

0.05

1.4

1.8

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

694

1.02

0.04

2.6

3.7

mg/l

32.7

75.5

1.35

575

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

377

1.03

0.04

1.1

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

675

1.02

0.04

2.4

3.7

ratio

22.4

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

102

1037

0.98

0.04

2.3

2.6

1.2

0.18

102

1030

(40760888) Immunoglobulin light chains.free panel - Serum

517

1.03

0.04

2.8

3.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

121

1.07

0.03

1.2

1.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

442

0.97

0.03

1.1

1.2

u/ml

185.6

260.2

1.57

277

(3027923) C peptide [Moles/volume] in Serum or Plasma

139

0.93

0.03

1.9

1.4

nmol/l

1.2

—

112

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

149

0.94

0.03

1.2

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

280

0.96

0.03

1.0

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

619

1.02

0.02

2.3

2.7

g/l

0.0

0.49

574

(3052851) Hemolysis interference index of Serum or Plasma

689

1.02

0.02

3.8

3.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

651

1.01

0.01

1.5

1.4

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

137

0.95

0.01

1.0

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

173

1.04

0.01

2.1

2.2

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

363

3619

1.00

0.01

3.3

2.8

e6/l

3.1

2.8

0.21

216

1944

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

141

1419

0.99

0.01

7.3

9.4

0.7

0.25

141

1408

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

253

1.03

0.01

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

473

1.02

0.01

1.1

1.4

—

(1616796) Gas panel - Central venous blood

487

0.99

0.01

4.1

3.5

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

613

1.01

0.01

2.3

2.7

g/l

0.0

0.00

573

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

100

1007

0.99

0.01

1.4

1.5

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

124

1.05

0.00

1.9

1.6

—

(3012544) pH of Venous blood

210

2093

1.00

0.00

3.9

3.7

—

7.4

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

145

0.97

0.00

1.9

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

235

1.02

0.00

1.3

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

159

1.01

0.00

8.3

6.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

365

1.01

0.00

1.4

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

124

0.97

0.00

2.0

1.6

—

(3014007) Fractional oxyhemoglobin in Arterial blood

142

1421

1.00

0.00

7.3

9.4

94.7

94.0

2.41

142

1413

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

174

0.98

0.00

1.1

2.5

e6/l

725.4

712.4

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

283

2831

1.00

0.00

5.8

7.0

mmol/l

104.7

104.4

0.55

278

2770

(3017569) Oxygen content in Arterial blood

112

0.98

0.00

1.6

2.5

—

(3039443) Prostate specific Ag panel - Serum or Plasma

348

1.01

0.00

1.4

1.6

—

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

142

1423

1.00

0.00

7.2

9.2

1.3

0.41

142

1412

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

147

1.02

0.00

1.3

2.8

54.5

39.7

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

147

1.02

0.00

1.5

1.3

u/l

11.0

12.0

0.15

132

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.1

—

1.7

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(3034426) Prothrombin time (PT)

0.94

0.00

1.4

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

0.98

0.00

2.9

2.6

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.1

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

2.5

—

(40765096) Chromosome analysis panel by Banding

0.90

0.00

1.1

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1308.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.95

0.00

1.0

1.4

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

0.99

0.00

1.3

1.1

—

(3042301) Urate [Moles/volume] in Synovial fluid

0.00

0.0

1.0

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.00

0.0

1.0

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

1.02

0.00

1.0

1.3

—

(3038385) Creatinine [Moles/volume] in Peritoneal fluid

0.00

0.0

1.4

—

164.6

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.92

0.00

1.0

1.2

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.01

0.00

1.3

1.1

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

0.99

0.00

1.1

1.2

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.0

5.8

—

0.2

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.97

0.00

1.3

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

0.95

0.00

1.0

2.9

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.00

0.0

1.0

—

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3001186) Copper [Moles/volume] in Serum or Plasma

0.88

0.00

1.8

1.2

umol/l

16.4

17.3

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.00

0.00

1.2

—

(3046861) Legionella sp Ag [Presence] in Urine

0.00

0.0

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

1.02

0.00

1.4

1.3

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.00

0.0

3.6

—

67.5

—

(3049242) von Willebrand panel - Platelet poor plasma

0.00

0.0

2.2

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.00

0.0

1.3

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

0.00

0.0

1.2

—

(3042733) HLA Ab [Presence] in Serum

0.87

0.00

3.0

4.4

—

(3009871) Measles virus Ab [Titer] in Serum

0.96

0.00

1.8

1.7

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

0.00

0.0

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.0

—

(3033799) Differential panel - Peritoneal fluid

0.95

0.00

1.4

2.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint RHINITIS_VASOMOTOR and mortality.

Females

Parameter	HR [95% CI]	p-value
RHINITIS_VASOMOTOR	0.877 [0.78, 0.98]	0.021
Birth year	0.999 [0.99, 1.01]	0.818

During the follow-up period (1.1.1998 — 31.12.2019), 736 out of 10047 females with RHINITIS_VASOMOTOR died.

Males

Parameter	HR [95% CI]	p-value
RHINITIS_VASOMOTOR	0.866 [0.77, 0.97]	0.011
Birth year	0.984 [0.97, 0.99]	0.001

During the follow-up period (1.1.1998 — 31.12.2019), 835 out of 7091 males with RHINITIS_VASOMOTOR died.

Mortality risk

Mortality risk for people of age

years, who have RHINITIS_VASOMOTOR.

N-year risk	Females	Males
1	0.106%	0.16%
5	0.563%	0.996%
10	1.343%	2.368%
15	2.626%	4.437%
20	4.741%	7.455%

Relationships between endpoints

↥

Index endpoint: RHINITIS_VASOMOTOR – Vasomotor rhinitis (mode)

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Vasomotor rhinitis (mode)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints